{
    "2019-08-05": [
        [
            {
                "time": "2019-08-05",
                "original_text": "The Vanguard Health Care Fund Buys Pfizer, Humana",
                "features": {
                    "keywords": [
                        "Vanguard",
                        "Health Care Fund",
                        "Pfizer",
                        "Humana"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "Investors Don’t Like Mylan’s Deal With Pfizer",
                "features": {
                    "keywords": [
                        "Investors",
                        "Mylan",
                        "Deal",
                        "Pfizer"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "The Zacks Analyst Blog Highlights: Caterpillar, Walmart, McDonald's, Pfizer and Marsh & McLennan",
                "features": {
                    "keywords": [
                        "Zacks",
                        "Analyst Blog",
                        "Caterpillar",
                        "Walmart",
                        "McDonald's",
                        "Pfizer",
                        "Marsh & McLennan"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "industrials",
                        "retail",
                        "food service",
                        "healthcare",
                        "insurance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "52-Week Company Lows",
                "features": {
                    "keywords": [
                        "52-Week",
                        "Company Lows"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "Health Care Sector Update for 08/05/2019: GLYC, PRVB, ZYME, JNJ, PFE, ABT, MRK, AMGN",
                "features": {
                    "keywords": [
                        "Health Care Sector",
                        "GLYC",
                        "PRVB",
                        "ZYME",
                        "JNJ",
                        "PFE",
                        "ABT",
                        "MRK",
                        "AMGN"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "Pfizer Falls 3%",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Falls"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "GlycoMimetics stock down 53% after Phase 3 trial failure",
                "features": {
                    "keywords": [
                        "GlycoMimetics",
                        "stock",
                        "down",
                        "Phase 3",
                        "trial",
                        "failure"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-08-05",
                "original_text": "GlycoMimetics Plummets After Phase 3 Trial of Sickle Cell Treatment Fails",
                "features": {
                    "keywords": [
                        "GlycoMimetics",
                        "Plummets",
                        "Phase 3",
                        "Trial",
                        "Sickle Cell",
                        "Treatment",
                        "Fails"
                    ],
                    "sentiment_score": -0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}